Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Status:
Active, not recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This study was to evaluate the efficacy and safety of Chidamide in combination with
exemestane in postmenopausal patients with hormone-receptor positive advanced breast cancer.